Researchers show the interplay of socioeconomic status and genetics on disease risk

FHS
June 3, 2024
7:07 pm

Differences in socioeconomic status (SES) are known to be linked to differences in the risk of developing disease.

FDA issues second CRL to Supernus for Parkinson’s drug-device combo

It seems Supernus Pharmaceuticals will need a super effort to get its Parkinson’s treatment approved. The FDA rejected the company’s therapy for a second time

April 9, 2024

Human post-implantation embryo models show promise in unraveling early development

Researchers evaluate post-implantation development in humans using embryo-like models based on genetically unmodified human naïve embryonic stem cells.

September 12, 2023

Diabetes drug dulaglutide may reduce symptoms of depression

The current study highlighted the antidepressant effects of dulaglutide using the CMS depression model. Notably, the potential metabolisms that underlie the antidepressant effect of dulaglutide

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.